Prevalence and ramifications of chronic constipation

Lucinda A. Harris

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

Constipation is a common condition, affecting 2% to 27% of North Americans. Arriving at true prevalence rates is complicated, because consensus definitions are lacking. Constipation has daily implications for those affected, and, although only one-third of affected persons seek care, it is associated with high socioeconomic costs. Traditional interventions, such as fiber and laxatives, are often recommended, but high-quality evidence of their efficacy is lacking and patient dissatisfaction is common. Improved understanding of the pathophysiology of constipation has resulted in the development and approval of a new agent for the treatment of patients with chronic idiopathic constipation.

Original languageEnglish (US)
Pages (from-to)23-30
Number of pages8
JournalManaged Care Interface
Volume18
Issue number8
StatePublished - Aug 2005

Fingerprint

Constipation
Laxatives
Proxy
Costs and Cost Analysis
Therapeutics

ASJC Scopus subject areas

  • Health Policy

Cite this

Prevalence and ramifications of chronic constipation. / Harris, Lucinda A.

In: Managed Care Interface, Vol. 18, No. 8, 08.2005, p. 23-30.

Research output: Contribution to journalArticle

Harris, Lucinda A. / Prevalence and ramifications of chronic constipation. In: Managed Care Interface. 2005 ; Vol. 18, No. 8. pp. 23-30.
@article{907dc778eef84b49ae9ad41381f385e9,
title = "Prevalence and ramifications of chronic constipation",
abstract = "Constipation is a common condition, affecting 2{\%} to 27{\%} of North Americans. Arriving at true prevalence rates is complicated, because consensus definitions are lacking. Constipation has daily implications for those affected, and, although only one-third of affected persons seek care, it is associated with high socioeconomic costs. Traditional interventions, such as fiber and laxatives, are often recommended, but high-quality evidence of their efficacy is lacking and patient dissatisfaction is common. Improved understanding of the pathophysiology of constipation has resulted in the development and approval of a new agent for the treatment of patients with chronic idiopathic constipation.",
author = "Harris, {Lucinda A.}",
year = "2005",
month = "8",
language = "English (US)",
volume = "18",
pages = "23--30",
journal = "Managed Care Interface",
issn = "1096-5645",
publisher = "Medicom International, Inc.",
number = "8",

}

TY - JOUR

T1 - Prevalence and ramifications of chronic constipation

AU - Harris, Lucinda A.

PY - 2005/8

Y1 - 2005/8

N2 - Constipation is a common condition, affecting 2% to 27% of North Americans. Arriving at true prevalence rates is complicated, because consensus definitions are lacking. Constipation has daily implications for those affected, and, although only one-third of affected persons seek care, it is associated with high socioeconomic costs. Traditional interventions, such as fiber and laxatives, are often recommended, but high-quality evidence of their efficacy is lacking and patient dissatisfaction is common. Improved understanding of the pathophysiology of constipation has resulted in the development and approval of a new agent for the treatment of patients with chronic idiopathic constipation.

AB - Constipation is a common condition, affecting 2% to 27% of North Americans. Arriving at true prevalence rates is complicated, because consensus definitions are lacking. Constipation has daily implications for those affected, and, although only one-third of affected persons seek care, it is associated with high socioeconomic costs. Traditional interventions, such as fiber and laxatives, are often recommended, but high-quality evidence of their efficacy is lacking and patient dissatisfaction is common. Improved understanding of the pathophysiology of constipation has resulted in the development and approval of a new agent for the treatment of patients with chronic idiopathic constipation.

UR - http://www.scopus.com/inward/record.url?scp=23844540986&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=23844540986&partnerID=8YFLogxK

M3 - Article

VL - 18

SP - 23

EP - 30

JO - Managed Care Interface

JF - Managed Care Interface

SN - 1096-5645

IS - 8

ER -